NT_1170x120_1-11-18

aspirin and extended-release dipyridamole capsules

Dr. Reddy’s rolls out aspirin and extended-release dipyridamole capsules

Dr. Reddy’s rolls out aspirin and extended-release dipyridamole capsules

PRINCETON, N.J. — Dr. Reddy’s Laboratories Ltd. recently announced the launch of aspirin and extended-release dipyridamole capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) capsules in the United States market from the U.S. Food and Drug Administration. The Aggrenox brand and generic had U.S. sales of approximately $182 million MAT for

Dr. Reddy’s receives approval for aspirin and extended-release dipyridamole capsules

Dr. Reddy’s receives approval for aspirin and extended-release dipyridamole capsules

HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories  announced receipt of approval for aspirin and extended-release dipyridamole capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) Capsules in the United States market from the U.S. Food and Drug Administration. The company is working towards launching the product. The Aggrenox brand and